Table 5.

Mean ALT and AST levels of participants by group and time period.

	VCO (n = 29)	CONTROL (n = 28)	-
	mean ± SE	mean ± SE
Alanine Transaminase (ALT), L−1
Baseline	37.1 ± 4.9	45.0 ± 5.4	0.285
Midline	71.0 ± 12.4	55.2 ± 8.2	0.295
Mean Difference (p-value2)	33.9 (0.001)*	10.2 (0.161)	0.049*
Baseline	37.1 ± 4.9	45.0 ± 5.4	0.285
Endpoint	63.6 ± 10.2	49.5 ± 7.1	0.263
Mean Difference (p-value2)	26.4 (<0.001)*	4.5 (0.314)	0.008*
p-value3	<0.001*	0.268
Aspartate Aminotransferase (AST), L−1
Baseline	27.3 ± 1.8	36.0 ± 2.5	0.007*
Midline	36.4 ± 3.6	32.7 ± 2.2	0.388
Mean Difference (p-value2)	9.1 (0.004)*	3.3 (0.175)	0.001*
Baseline	27.3 ± 1.8	36.0 ± 2.5	0.007*
Endpoint	37.4 ± 3.3	32.7 ± 2.5	0.266
Mean Difference (p-value2)	10.1 (<0.001)*	3.3 (0.189)	0.001*
p-value3	0.001*	0.242

¹Independent t-test,

²Paired t-test,

³Anova with repeated measure (baseline, midline, and endpoint).

^*significant at p < 0.05.